Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
50 studies found for:    " September 02, 2009":" October 02, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 1;   Drug: Placebo
22 Unknown  Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 2;   Drug: Placebo
23 Unknown  The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 3;   Drug: Fuzheng 1;   Drug: Placebo
24 Completed Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose
Conditions: Immunologic Tests;   HIV Infections
Interventions: Biological: GSK Biologicals' HIV vaccine (732461);   Drug: Chloroquine
25 Completed
Has Results
Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
Conditions: HIV Infections;   Dyslipidemia;   Endothelial Dysfunction
Intervention: Drug: extended release niacin
26 Completed Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: mefloquine
27 Completed Pharmacokinetics of Lamivudine at Two Different Doses
Condition: HIV Infections
Intervention: Drug: Lamivudine (3TC)
28 Completed Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis
Conditions: Cryptococcal Meningitis;   HIV Infections
Intervention: Other: Early antiretroviral therapy
29 Unknown  Effect of Rosuvastatin on Endothelial Function
Conditions: HIV Infections;   Cardiovascular Disease
Intervention: Drug: rosuvastatin
30 Completed Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients
Conditions: HIV Infections;   Neisseria Gonorrhoeae;   Chlamydia Trachomatis;   Herpes Simplex
Intervention:
31 Completed Infant Male Circumcision in Gaborone, Botswana, and Surrounding Areas: Feasibility, Safety and Acceptability
Conditions: HIV Infections;   Circumcision
Interventions: Procedure: Circumcision;   Device: Mogen Clamp;   Device: Plastibell;   Device: AccuCirc
32 Completed Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort
Condition: HIV Infections
Intervention:
33 Completed Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients
Conditions: HIV Infections;   Lipoatrophy
Interventions: Drug: EFV;   Drug: LPV/r
34 Completed Mothers Living With HIV and Their Adolescent Children
Conditions: Family Relations;   Mental Health;   Physical Health;   Risky Sexual Behavior;   Substance Use;   HIV Infections
Intervention: Behavioral: Cognitive-behavioral, small-group format sessions
35 Completed Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).
Condition: HIV
Interventions: Drug: HAART;   Drug: HAART + Immunotherapy
36 Completed
Has Results
Cardiovascular Prevention for Persons With HIV
Conditions: HIV Infection;   Cardiovascular Disease Risk
Interventions: Drug: Pravastatin;   Drug: Lisinopril
37 Completed Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
Condition: HIV Infections
Interventions: Drug: Raltegravir (RAL);   Drug: Atazanavir (ATV);   Drug: Ritonavir (RTV);   Drug: Tenofovir (TDF);   Drug: Etravirine (ETV);   Drug: Darunavir (DRV);   Drug: Maraviroc (MVC);   Drug: Lopinavir/ritonavir (LPV/r)
38 Completed
Has Results
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: telaprevir or matching placebo;   Biological: peginterferon alfa-2a;   Drug: ribavirin (fixed dose);   Drug: ribavirin (weight-based dose)
39 Completed
Has Results
The Raltegravir and Ribavirin Pharmacokinetics (PK) Study
Condition: HIV Infections
Interventions: Drug: Ribavirin;   Drug: Raltegravir
40 Completed
Has Results
Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune
Condition: HIV Infections
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results    Last Page
Indicates status has not been verified in more than two years